SCHEMBL26458455

SCHEMBL26458455

c1ccc(-c2nc(-c3ccccc3)nc(-c3cccc4c3C3(c5ccccc5Oc5ccccc53)c3cccc(-c5cnc6ccccc6n5)c3-4)n2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 7/20 0.36
RAB9A P51151 6/20 0.36
KMT2A Q03164 3/20 0.34
JAK2 O60674 1/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
BCHE P06276 1/20 0.33
MEN1 O00255 2/20 0.32
ALDH1A1 P00352 1/20 0.32
MAPT P10636 1/20 0.32
ALOX12 P18054 1/20 0.32
MAPK10 P53779 1/20 0.32
ATM Q13315 1/20 0.32
HSP90AA1 P07900 1/20 0.32
HSP90AB1 P08238 1/20 0.32
ADORA3 P0DMS8 1/20 0.32
ADORA2A P29274 1/20 0.32
ADORA1 P30542 1/20 0.32
TP53 P04637 1/20 0.31
STAT1 P42224 1/20 0.31
TLR9 Q9NR96 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26458054 0.97 NPC1 (0.36) NPC1RAB9AKMT2AJAK2SMN1; SMN2
SCHEMBL26458606 0.92 NPC1 (0.39) NPC1RAB9AKMT2AJAK2SMN1; SMN2
SCHEMBL26457938 0.91 NPC1 (0.37) NPC1RAB9AKMT2AJAK2SMN1; SMN2
SCHEMBL26458253 0.88 NPC1 (0.37) NPC1RAB9AKMT2AJAK2SMN1; SMN2
SCHEMBL26458083 0.87 NPC1 (0.36) NPC1RAB9AKMT2AJAK2SMN1; SMN2
SCHEMBL26458064 0.86 TSHR (0.35) NPC1RAB9AKMT2ASMN1; SMN2MEN1
SCHEMBL26458556 0.85 NPC1 (0.42) NPC1RAB9AKMT2AJAK2SMN1; SMN2
SCHEMBL22216541 0.85 TSHR (0.38) SMN1; SMN2ALDH1A1MAPTATMADORA3
SCHEMBL26458393 0.85 NPC1 (0.38) NPC1RAB9AKMT2AJAK2SMN1; SMN2
SCHEMBL26458445 0.84 MEN1 (0.40) KMT2ASMN1; SMN2MEN1ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11641778-B2 Compound and organic light emitting device comprising same LG CHEM, LTD. (KR) 2023-05-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11641778-B2 Compound and organic light emitting device comprising same CRY1, CYP1A1, CRY2 NPC1 1521/4885RAB9A 2344/4885KMT2A 1182/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.